When electric-vehicle manufacturer Rivian stock (NASDAQ:RIVN) entered the scene, its debut represented a breath of fresh air. While Tesla (NASDAQ:TSLA) remains the sector leader, its designs have arguably become predictable and therefore stale. On the other hand, Rivian effortlessly blended classic lines with modern accoutrements, thus bolstering the case (at the time of its debut)
0 Comments
The future of the U.S. economy appears promising, with robust growth and strong corporate performance. This economic strength has propelled the stock market to record highs, signaling confidence in the economy’s resilience. The well established pharmaceutical industry continues to assert its economic dominance through resolute financials. In 2022, pharma stocks brought in $510.5 billion, with
0 Comments
As the state of Maryland works to recover from the Baltimore bridge disaster, potential long-term financial consequences are becoming present. With each passing day, the gargantuan task of recovering and removing debris from the seafloor slows Baltimore’s local economy. Currently, the major hurdle for the Unified Command handling the situation consists of removing enough containers
0 Comments
Known for her focus on innovative disruption, Cathie Wood has become one of the biggest names in capital management. With her firm, ARK Invest, Wood has created custom exchange-traded funds focused on aggregating high-potential stocks. Much of her portfolio focuses on technologies like genomics, artificial intelligence, robotics, clean energy and blockchain technology. This makes for
0 Comments
Dividend stocks allow investors to get paid just by holding onto shares. This investing model can help people cover their living costs without having to sell shares. Some corporations offer high yields with limited upside in their stock prices. Other businesses have low yields but plenty of upside. Investors should consider whether they prioritize growth
0 Comments
Finding high-return potential in the market may be both thrilling and intimidating. These stocks present prospects because of their strategic placement within the information technology industry and their skill in identifying and following new market trends. The first, for example, positions itself at the forefront of blockchain technology and crypto analytics by leveraging the growing
0 Comments
There are some pharma stocks to sell in April. Holding these companies is too risky, especially as the industry faces increasing regulatory scrutiny and pricing pressures. Several major pharmaceutical firms are grappling with patent cliffs, where key drug exclusivities are expiring. This opens the door for generic competition. Moreover, with the broader market presenting attractive
0 Comments